Vascular Solutions Reports Second Quarter Results
22 juil. 2014 16h05 HE
|
Vascular Solutions, Inc.
- Record quarterly revenues increase 12% to $30.7 million
- GAAP earnings per share increase 9% to $0.18
- Raising bottom-end of 2014 revenue guidance range to $123 million from $121 million,...
Vascular Solutions, Inc. Issues Recall of Langston(R) Dual Lumen Catheters
03 juil. 2014 16h05 HE
|
Vascular Solutions, Inc.
MINNEAPOLIS, July 3, 2014 (GLOBE NEWSWIRE) -- On May 23, 2014, Vascular Solutions, Inc. (Nasdaq:VASC) initiated a voluntary nationwide recall of Langston dual lumen catheters used in catheterization...
Vascular Solutions, Inc. to Webcast Second Quarter Conference Call
01 juil. 2014 16h05 HE
|
Vascular Solutions, Inc.
MINNEAPOLIS, July 1, 2014 (GLOBE NEWSWIRE) -- Vascular Solutions, Inc. (Nasdaq:VASC) today announced that it will host a live webcast of its second quarter conference call on Tuesday, July 22nd at...
Vascular Solutions Launches Gel-Bead(TM) Embolization Spheres
19 juin 2014 16h05 HE
|
Vascular Solutions, Inc.
- Precisely sized, bioresorbable gelatin beads intended for embolization of hypervascular tumors
- Designed for use by interventional radiologists who currently use microspheres, PVA particles,...
Vascular Solutions to Participate in Bank of America Merrill Lynch 2014 Health Care Conference
01 mai 2014 16h05 HE
|
Vascular Solutions, Inc.
MINNEAPOLIS, May 1, 2014 (GLOBE NEWSWIRE) -- Vascular Solutions, Inc. (Nasdaq:VASC) today announced that the Company is scheduled to participate in the Bank of America Merrill Lynch 2014 Health Care...
Vascular Solutions Reports First Quarter Results
22 avr. 2014 16h05 HE
|
Vascular Solutions, Inc.
Record revenues increase 15% to $29.9 million, reflecting growth in all three product categories
EPS increases 26% to $0.16, including above-budget legal expenses that reduced first quarter...
Vascular Solutions Enters Into Agreement With U.S. Army to Develop Freeze-Dried Plasma Product
22 avr. 2014 16h03 HE
|
Vascular Solutions, Inc.
- U.S. Army will sponsor, conduct and fund all Food and Drug Administration (FDA) required pre-clinical and clinical studies of the freeze-dried plasma product developed by Vascular Solutions
-...
Preliminary Injunction Against Boston Scientific's Guidezilla(TM) Catheter Vacated by Federal Circuit
15 avr. 2014 11h50 HE
|
Vascular Solutions, Inc.
MINNEAPOLIS, April 15, 2014 (GLOBE NEWSWIRE) -- Vascular Solutions, Inc. (Nasdaq:VASC) announced that a three judge panel of the U.S. Court of Appeals for the Federal Circuit today vacated the...
Vascular Solutions Surpasses 50,000 Successfully Reprocessed ClosureFAST(R) Catheters
09 avr. 2014 16h05 HE
|
Vascular Solutions, Inc.
-- Reprocessing of popular vein treatment catheter results in significant cost savings and reduced medical waste for U.S. vein clinics
-- Excellent safety record established, with no serious...
Vascular Solutions, Inc. to Webcast First Quarter Conference Call
08 avr. 2014 16h05 HE
|
Vascular Solutions, Inc.
MINNEAPOLIS, April 8, 2014 (GLOBE NEWSWIRE) -- Vascular Solutions, Inc. (Nasdaq:VASC) today announced that it will host a live webcast of its first quarter conference call on Tuesday, April 22nd at...